Phase 1 Influenza, Human Clinical Trials

4 recruitingPhase 1

What is a Phase 1 trial?

Phase 1 trials test a new treatment in a small group of people for the first time. The primary goal is to evaluate safety, determine a safe dosage range, and identify side effects. These studies typically enroll 20 to 80 participants.

Showing 1–4 of 4 trials

Recruiting

Phase 1

A Study on the Safety and Immune Response of Investigational mRNA Seasonal Flu/COVID-19 Combination Vaccine in Adults

Influenza, Human+COVID-19

GlaxoSmithKline225 enrolled12 locationsNCT07464314

Recruiting

Phase 1Phase 2

Study on Safety and Efficacy of Two Doses of PRS CK STORM in the Modulation of the Cytokine Storm in Patients With Acute Respiratory Infection Caused by SARS-Cov-2, Influenza A, Influenza B and Respiratory Syncytial Virus (RSV)

Systemic Inflammatory Response SyndromeSARS CoV-2Respiratory distress syndrome+2 more

PEACHES BIOTECH50 enrolled3 locationsNCT06684379

Recruiting

Phase 1Phase 2

Clinical Trials of Quadrivalent Influenza Vaccine

Influenza, Human

Anhui Zhifei Longcom Biologic Pharmacy Co., Ltd.620 enrolled1 locationNCT06824519

Recruiting

Phase 1

Covid-19 and Influenza Oral Vaccine Study

Influenza, Humancovid19 Infection

Vaxine Pty Ltd100 enrolled1 locationNCT06355232